Treatment Effectiveness
User reported effectiveness ratings Glucosamine for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Arthritic Hips | 5% | 19% | 5% | 67% | 5% | 21 |
| Arthritis | 4% | 18% | 5% | 69% | 4% | 77 |
| Ehlers-Danlos Syndrome, Hypermobility | 0% | 14% | 11% | 69% | 6% | 35 |
| Fibromyalgia | 1% | 16% | 3% | 75% | 4% | 174 |
| Interstitial Cystitis | 0% | 29% | 0% | 71% | 0% | 7 |
| Knee Pain | 2% | 19% | 5% | 68% | 5% | 133 |
| Osteoarthritis | 4% | 26% | 0% | 67% | 4% | 27 |
| Rheumatoid Arthritis | 0% | 12% | 14% | 67% | 7% | 42 |
Outcomes
Below is the degree of change seen after Glucosamine is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Outcomes Label
Glucosamine Info
| Property | Value |
|---|---|
| Variable Name | Glucosamine |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-03-16 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 93702 |